Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Initial medication non-adherence: Prevalence and predictive factors in a cohort of 1.6 million Primary Care patients.

Aznar-Lou I, Fernández A, Gil-Girbau M, Fajó-Pascual M, Moreno-Peral P, Peñarrubia-Maria MT, Serrano-Blanco A, Sánchez-Niubó A, March-Pujol M, Jové AM, Rubio-Valera M.

Br J Clin Pharmacol. 2017 Feb 23. doi: 10.1111/bcp.13215. [Epub ahead of print]

PMID:
28229476
2.

A model for continuous monitoring of patients with major depression in short and long term periods.

Mugica F, Nebot À, Bagherpour S, Baladón L, Serrano-Blanco A.

Technol Health Care. 2016 Dec 16. doi: 10.3233/THC-161289. [Epub ahead of print]

PMID:
28009344
3.

Qualitative study of the agitation states and their characterization, and the interventions used to attend them.

Rubio-Valera M, Huerta-Ramos E, Baladón L, Aznar-Lou I, Ortiz-Moreno JM, Luciano JV, Roset-Arisso PN, Salvador-Carulla L, Villagrán JM, Mayoral F, Gracia A, Serrano-Blanco A.

Actas Esp Psiquiatr. 2016 Sep;44(5):166-77.

PMID:
27644098
4.

Corrigendum: Bifactor analysis and construct validity of the Five Facet Mindfulness Questionnaire (FFMQ) in non-clinical Spanish samples.

Aguado J, Luciano JV, Cebolla A, Serrano-Blanco A, Soler J, García-Campayo J.

Front Psychol. 2016 May 9;7:706. doi: 10.3389/fpsyg.2016.00706.

PMID:
27242618
5.

Corrigendum to: "Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trial" [Eur. Neuropsychopharmacol. 23(2013)1057-1066].

Rubio-Valera M, Pujol MM, Fernández A, Peñarrubia-María MT, Travé P, Del Hoyo YL, Serrano-Blanco A.

Eur Neuropsychopharmacol. 2016 Jun;26(6):1085. doi: 10.1016/j.euroneuro.2016.02.016. No abstract available.

PMID:
27161840
6.

Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia.

Hargarter L, Bergmans P, Cherubin P, Keim S, Conca A, Serrano-Blanco A, Bitter I, Bilanakis N, Schreiner A.

Expert Opin Pharmacother. 2016 Jun;17(8):1043-53. doi: 10.1080/14656566.2016.1174692.

PMID:
27042990
7.

Intervention to Prevent Major Depression in Primary Care: A Cluster Randomized Trial.

Bellón JÁ, Conejo-Cerón S, Moreno-Peral P, King M, Nazareth I, Martín-Pérez C, Fernández-Alonso C, Rodríguez-Bayón A, Fernández A, Aiarzaguena JM, Montón-Franco C, Ibanez-Casas I, Rodríguez-Sánchez E, Ballesta-Rodríguez MI, Serrano-Blanco A, Gómez MC, LaFuente P, Muñoz-García Mdel M, Mínguez-Gonzalo P, Araujo L, Palao D, Bully P, Zubiaga F, Navas-Campaña D, Mendive J, Aranda-Regules JM, Rodriguez-Morejón A, Salvador-Carulla L, de Dios Luna J.

Ann Intern Med. 2016 May 17;164(10):656-65. doi: 10.7326/M14-2653.

PMID:
27019334
8.

Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study).

Feliu-Soler A, Borràs X, Peñarrubia-María MT, Rozadilla-Sacanell A, D'Amico F, Moss-Morris R, Howard MA, Fayed N, Soriano-Mas C, Puebla-Guedea M, Serrano-Blanco A, Pérez-Aranda A, Tuccillo R, Luciano JV.

BMC Complement Altern Med. 2016 Feb 27;16:81. doi: 10.1186/s12906-016-1068-2.

PMID:
26921267
9.

Attitudes and intended behaviour to mental disorders and associated factors in catalan population, Spain: cross-sectional population-based survey.

Aznar-Lou I, Serrano-Blanco A, Fernández A, Luciano JV, Rubio-Valera M.

BMC Public Health. 2016 Feb 9;16:127. doi: 10.1186/s12889-016-2815-5.

PMID:
26861632
10.

Correction: Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study).

Rubio-Valera M, Bosmans J, Fernández A, Peñarrubia-María M, March M, Travé P, Bellón JA, Serrano-Blanco A.

PLoS One. 2016 Jan 14;11(1):e0147459. doi: 10.1371/journal.pone.0147459. No abstract available.

PMID:
26765519
11.

Impact of the mass media OBERTAMENT campaign on the levels of stigma among the population of Catalonia, Spain.

Rubio-Valera M, Fernández A, Evans-Lacko S, Luciano JV, Thornicroft G, Aznar-Lou I, Serrano-Blanco A.

Eur Psychiatry. 2016 Jan;31:44-51. doi: 10.1016/j.eurpsy.2015.10.005.

PMID:
26675784
12.

Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.

Luciano JV, Forero CG, Cerdà-Lafont M, Peñarrubia-María MT, Fernández-Vergel R, Cuesta-Vargas AI, Ruíz JM, Rozadilla-Sacanell A, Sirvent-Alierta E, Santo-Panero P, García-Campayo J, Serrano-Blanco A, Pérez-Aranda A, Rubio-Valera M.

Clin J Pain. 2016 Oct;32(10):829-40. doi: 10.1097/AJP.0000000000000336.

PMID:
26633691
13.

Gender differences in the impact of mental disorders and chronic physical conditions on health-related quality of life among non-demented primary care elderly patients.

Baladón L, Rubio-Valera M, Serrano-Blanco A, Palao DJ, Fernández A.

Qual Life Res. 2016 Jun;25(6):1461-74. doi: 10.1007/s11136-015-1182-5.

PMID:
26590837
14.

Pilot randomised controlled trial of Help4Mood, an embodied virtual agent-based system to support treatment of depression.

Burton C, Szentagotai Tatar A, McKinstry B, Matheson C, Matu S, Moldovan R, Macnab M, Farrow E, David D, Pagliari C, Serrano Blanco A, Wolters M; Help4Mood Consortium..

J Telemed Telecare. 2016 Sep;22(6):348-55. doi: 10.1177/1357633X15609793.

PMID:
26453910
15.

[Impact of pharmaceutical intervention in preventing relapses in depression in Primary Care].

Rubio-Valera M, Peñarrubia-María MT, Fernández-Vergel R, Carvajal Tejadillo AC, Fernández Sánchez A, Aznar-Lou I, March-Pujol M, Serrano-Blanco A.

Aten Primaria. 2016 May;48(5):308-15. doi: 10.1016/j.aprim.2015.05.009. Spanish.

PMID:
26415743
16.

Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users.

de Araújo AA, Ribeiro SB, Dos Santos AC, Lemos TM, Medeiros CA, Guerra GC, de Araújo Júnior RF, Serrano-Blanco A, Rubio-Valera M.

Psychiatr Q. 2016 Jun;87(2):293-304. doi: 10.1007/s11126-015-9385-z.

PMID:
26220635
17.

Bifactor analysis and construct validity of the five facet mindfulness questionnaire (FFMQ) in non-clinical Spanish samples.

Aguado J, Luciano JV, Cebolla A, Serrano-Blanco A, Soler J, García-Campayo J.

Front Psychol. 2015 Apr 9;6:404. doi: 10.3389/fpsyg.2015.00404. Erratum in: Front Psychol. 2016;7:706.

PMID:
25914664
18.

Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).

Rubio-Valera M, Beneitez I, Peñarrubia-María MT, Luciano JV, Mendive JM, McCrone P, Knapp M, Sabés-Figuera R, Kocyan K, García-Campayo J, Serrano-Blanco A.

BMC Psychiatry. 2015 Mar 31;15:63. doi: 10.1186/s12888-015-0448-3.

PMID:
25885818
19.

Health service use and costs associated with aggressiveness or agitation and containment in adult psychiatric care: a systematic review of the evidence.

Rubio-Valera M, Luciano JV, Ortiz JM, Salvador-Carulla L, Gracia A, Serrano-Blanco A.

BMC Psychiatry. 2015 Mar 4;15:35. doi: 10.1186/s12888-015-0417-x. Review.

PMID:
25881240
20.

Prevalence of mental disorders in non-demented elderly people in primary care--erratum.

Baladón L, Fernández A, Rubio-Valera M, Cuevas-Esteban J, Palao DJ, Bellon JA, Serrano-Blanco A.

Int Psychogeriatr. 2015 May;27(5):756. doi: 10.1017/S1041610215000575. No abstract available.

PMID:
25835501
Items per page

Supplemental Content

Loading ...
Support Center